Art

J-GLOBAL ID：201902239024892457   Reference number：19A0766049

Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma

肝脾T細胞リンパ腫への非血縁幹細胞移植前のゲムシタビン,カルボプラチン,デキサメタゾンによるブリッジング化学療法の成功

Author (21)： Okuni Marika (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Yakushijin Kimikazu (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Uehara Keiichiro (Department of Diagnostic Pathology, Kobe University Hospital, Japan) ,  Ichikawa Hiroya (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Suto Hirotaka (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Hashimoto Akiko (Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan) ,  Tanaka Yasuhiro (Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan) ,  Shinzato Isaku (Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Japan) ,  Sakai Rina (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Mizutani Yu (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Nagao Shigeki (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Kurata Keiji (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Kakiuchi Seiji (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Miyata Yoshiharu (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Inui Yumiko (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Saito Yasuyuki (Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Japan) ,  Kawamoto Shinichiro (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Yamamoto Katsuya (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Ito Mitsuhiro (Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Japan) ,  Matsuoka Hiroshi (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan) ,  Minami Hironobu (The Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 58  Issue： 5  Page： 707-712(J-STAGE)  Publication year： 2019 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： carboplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0766049&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (4)： hepatosplenic T-cell lymphoma ,  GCD ,  allogeneic stem cell transplantation ,  bridging therapy

JST classification (2)： Clinical oncology in general  (GE03010Y) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (2)： Gemcitabine ,  Dexamethasone

Reference (12)：

• 1. Vose J, Armitage J, Weisenburger D, International TCLP. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26: 4124-4130, 2008.
• 2. Durani U, Go RS. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States. Am J Hematol 92: E99-E101, 2017.
• 3. Yabe M, Medeiros LJ, Tang G, et al. Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol 40: 676-688, 2016.
• 4. Visnyei K, Grossbard ML, Shapira I. Hepatosplenic gammadelta T-cell lymphoma: an overview. Clin Lymphoma Myeloma Leuk 13: 360-369, 2013.
• 5. Rashidi A, Cashen AF. Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma. Blood Cancer J 5: e318, 2015.

Terms in the title (9)： 肝脾T細胞リンパ腫 ,  血縁 ,  幹細胞移植 ,  ゲムシタビン ,  カルボプラチン ,  デキサメタゾン ,  ブリッジング ,  化学療法 ,  成功